After-Hours Stock Movers:

Clarus (NASDAQ: CLAR) 16% LOWER; reported Q4 EPS of $0.20, $0.18 better than the analyst estimate of $0.02. Revenue for the quarter came in at $104.2 million versus the consensus estimate of $101.12 million. The Company expects fiscal year 2023 sales of approximately $420 million and adjusted EBITDA of approximately $60 million, or an adjusted EBITDA margin of 14.3%.

Progyny (NASDAQ: PGNY) 12% HIGHER; reported Q4 EPS of $0.03, $0.02 better than the analyst estimate of $0.01. Revenue for the quarter came in at $214.3 million versus the consensus estimate of $211.78 million.

Hims & Hers Health, Inc. (NYSE: HIMS) 10% HIGHER; reported Q4 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $167.2 million versus the consensus estimate of $160.8 million. Hims & Hers Health, Inc. sees Q1 2023 revenue of $175-180 million, versus the consensus of $163 million. Adjusted EBITDA of $3 million to $6 million, reflecting an Adjusted EBITDA margin of 2% to 3%. Hims & Hers Health, Inc. sees FY2023 revenue of $735-755 million, versus the consensus of $727 million. Adjusted EBITDA of $20 million to $30 million, reflecting an Adjusted EBITDA margin of 3% to 4%.

Zoom (NASDAQ: ZM) 8% HIGHER; reported Q4 EPS of $1.22, $0.41 better than the analyst estimate of $0.81. Revenue for the quarter came in at $1.12 billion versus the consensus estimate of $1.1 billion. Zoom sees Q1 2024 EPS of $0.96-$0.98, versus the consensus of $0.84. Zoom sees Q1 2024 revenue of $1.08-1.085 billion, versus the consensus of $1.11 billion. Zoom sees FY2024 EPS of $4.11-$4.18, versus the consensus of $3.65. Zoom sees FY2024 revenue of $4.435-4.455 billion, versus the consensus of $4.6 billion.

AAON, Inc. (NASDAQ: AAON) 4% HIGHER; reported Q4 EPS of $0.71, $0.15 better than the analyst estimate of $0.56. Revenue for the quarter came in at $254.6 million versus the consensus estimate of $240.28 million.